inhibited PDGF-BB-induced phosphorylation of focal adhesion kinase (FAK), suppressed FAK activity by binding in an ATP, reduced HASMC migration, inhibited PDGF-BB-induced FAK phosphorylation, F-actin reduction, and FAK activity, protected against atherosclerosis. Here, PTK2 is linked to atherosclerosis.